TNF and infection: Patients who are on TNF-α inhibitors may be immunocompromised to a degree and are therefore at a higher risk of developing infections of the GI tract including parasites (e.g., Cryptosporidium) and enteric bacteria (e.g., Salmonella, Shigella, Campylobacter, and Clostridium difficile).